Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Obrist

Showing results (41-50 of 63) with videos related to

Pageof 7
Sort By:
Onkologie|April 1, 1989
ABLETOP, a well-tolerated, effective regimen for relapsing Hodgkin's disease. Swiss Group for Clinical Cancer Research (SAKK)R Obrist, H P Honegger, M Aapro, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1991
Single high-dose recombinant human granulocyte-macrophage colony stimulating factor: results of a phase I tolerability studyA Dieterle, A Gratwohl, R Ritz, et al.
European Journal of Cancer & Clinical Oncology|March 1, 1987
Prevention of cytotoxic drug induced skin ulcers with dimethyl sulfoxide (DMSO) and alpha-tocopheroleC U Ludwig, H R Stoll, R Obrist, et al.
International Journal of Immunopharmacology|January 1, 1983
Monocyte chemotaxis mediated by formyl-methionyl-leucyl-phenylalanine conjugated with monoclonal antibodies against human ovarian carcinomaR Obrist, R Reilly, T Leavitt, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1979
Vindesine. A clinical trial with special reference to neurological side effectsR Obrist, U Paravicini, D Hartmann, et al.
The Journal of Experimental Medicine|February 1, 1988
Antibodies as antigens. The use of mouse monoclonal antibodies to focus human T cells against selected targetsA Lanzavecchia, S Abrignani, D Scheidegger, et al.
Invasion & Metastasis|January 1, 1989
Selection of highly malignant tumour cells using reconstituted basement membrane matrixK Tullberg, H Haidvogl, R Obrist, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1990
Recombinant interferon gamma up-regulates in vivo and down-regulates in vitro monocyte CD14 antigen expression in cancer patientsR Landmann, M Wesp, C Ludwig, et al.
Lancet (London, England)|July 13, 1991
Cancer treatment and old peopleU Tirelli, M Aapro, R Obrist, et al.
Schweizerische Medizinische Wochenschrift|July 16, 1977
[Differentiation of lymphocyte populations in the blood of breast-cancer patients]W Weber, G A Nagel, R Obrist, et al.
Pageof 7

Showing results (41-50 of 63) with videos related to

Sort By:
Pageof 7
Onkologie|April 1, 1989
ABLETOP, a well-tolerated, effective regimen for relapsing Hodgkin's disease. Swiss Group for Clinical Cancer Research (SAKK)R Obrist, H P Honegger, M Aapro, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1991
Single high-dose recombinant human granulocyte-macrophage colony stimulating factor: results of a phase I tolerability studyA Dieterle, A Gratwohl, R Ritz, et al.
European Journal of Cancer & Clinical Oncology|March 1, 1987
Prevention of cytotoxic drug induced skin ulcers with dimethyl sulfoxide (DMSO) and alpha-tocopheroleC U Ludwig, H R Stoll, R Obrist, et al.
International Journal of Immunopharmacology|January 1, 1983
Monocyte chemotaxis mediated by formyl-methionyl-leucyl-phenylalanine conjugated with monoclonal antibodies against human ovarian carcinomaR Obrist, R Reilly, T Leavitt, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1979
Vindesine. A clinical trial with special reference to neurological side effectsR Obrist, U Paravicini, D Hartmann, et al.
The Journal of Experimental Medicine|February 1, 1988
Antibodies as antigens. The use of mouse monoclonal antibodies to focus human T cells against selected targetsA Lanzavecchia, S Abrignani, D Scheidegger, et al.
Invasion & Metastasis|January 1, 1989
Selection of highly malignant tumour cells using reconstituted basement membrane matrixK Tullberg, H Haidvogl, R Obrist, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1990
Recombinant interferon gamma up-regulates in vivo and down-regulates in vitro monocyte CD14 antigen expression in cancer patientsR Landmann, M Wesp, C Ludwig, et al.
Lancet (London, England)|July 13, 1991
Cancer treatment and old peopleU Tirelli, M Aapro, R Obrist, et al.
Schweizerische Medizinische Wochenschrift|July 16, 1977
[Differentiation of lymphocyte populations in the blood of breast-cancer patients]W Weber, G A Nagel, R Obrist, et al.
Pageof 7